|
1. 1. Marilee D. Obritsch, PharmD, Douglas N. Nosocomial Infections Due to Multidrug-Resistant Pseudomonas Aeruginosa: Epidemiology and Treatment Options. Pharmacotherapy.2005;25(10):1353-1364.
2. Yetkin G1, Otlu B, Cicek A, Kuzucu C. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Am J Infect Control.2006;34(4):188-92.
3. Apostolos Liakopoulos, Angeliki Mavroid. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons. BMC Infectious Diseases.2013; 13:505
4. Mahboubi M, Feizabadi MM. Antifungal activity of essential oil from Oliveria decumbens Vent and its synergy with amphotricin B. Int. J. Essent. Oil Therapeut.2007; 2, 26–28.
5. Mohamed NM, Youssef AAF. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Microb. Drug Resist.2011; 17; 489-95.
6. Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. 2013;S0305-4179(13)00232-5.10.1016/j.
7. Gail M. Preston. Plant perceptions of plant growth-promoting Pseudomonas, 2004; 359, 907–918.
8. Shadia M, Abdel-Aziz , Aeron A. Bacterial Bioflm: Dispersal and Inhibition Strategies.SaJ –biotechnol.2014; 1(1):105.
9. M.-L. Lambert, C. Suetens, A. Savey et al., “Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study,” The Lancet Infectious Diseases, vol. 11, no. 1, pp. 30–38, 2011
10. W. H. Zhao and Z. Q. Hu, “β-lactamases identified in clinical isolates of Pseudomonas aeruginosa,” Critical Reviews in Microbiology, vol. 36, no. 3, pp. 245–258, and 2010.
11. Wayne PA. Performance standards for antimicrobial susceptibilty testing. Ninth informational supplement NCCLS document M100-S9. National Committee for Clinical Laboratory Standards. 2013.
12. Souha S. Kanj, Zeina A. Kanafani. Current Concepts in Antimicrobial Therapy against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosaMayo Clin Proc.2011; 86(3): 250–259.
|
